Detalhe da pesquisa
1.
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.
J Immunol
; 211(2): 219-228, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37204246
2.
Lymphangitic Melanomatosis: Case Report of Intralymphatic Spread of Melanoma in a 66-year-old Man.
Am J Dermatopathol
; 46(5): 316-319, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38574049
3.
Brief Report: Improving Fellow Performance of the Pharmacology Section of the American Society of Clinical Oncology In-Training Exam.
J Cancer Educ
; 38(1): 141-145, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34535877
4.
Seeking Racial Equity in Hematology and Oncology: a Fellow-Led Educational Series to Promote Reflection and Action.
J Cancer Educ
; 38(4): 1241-1244, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36598746
5.
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience.
Ann Surg Oncol
; 29(2): 791-801, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648098
6.
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.
BMC Cancer
; 22(1): 38, 2022 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34986841
7.
A hybrid model of acute unscheduled cancer care provided by a hospital-based acute care clinic and the emergency department: a descriptive study.
Support Care Cancer
; 29(12): 7479-7485, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34089356
8.
How well do documented goals-of-care discussions for patients with stage IV cancer reflect communication best practices?
BMC Palliat Care
; 20(1): 41, 2021 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691683
9.
Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience.
Oncology
; 98(3): 174-178, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31794964
10.
THYROID DYSFUNCTION, RECOVERY, AND PROGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE REVIEW.
Endocr Pract
; 26(1): 36-42, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31461358
11.
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma.
Br J Cancer
; 121(5): 417-420, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31353364
12.
Implementing a Program of Talimogene laherparepvec.
Ann Surg Oncol
; 25(7): 1828-1835, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29417403
13.
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
Invest New Drugs
; 36(1): 103-113, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29127533
14.
The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy.
Anticancer Drugs
; 28(6): 669-675, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28368903
15.
Medical Knowledge Assessment by Hematology and Medical Oncology In-Training Examinations Are Better Than Program Director Assessments at Predicting Subspecialty Certification Examination Performance.
J Cancer Educ
; 32(3): 647-654, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26897634
16.
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.
Ann Surg Oncol
; 23(13): 4169-4177, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27342831
17.
Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma.
J Comput Assist Tomogr
; 40(5): 803-5, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27636126
18.
ASO Author Reflections: Implementing a Program of Talimogene laherparepvec.
Ann Surg Oncol
; 25(Suppl 3): 920-921, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30421049
19.
Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial.
J Immunother Cancer
; 11(5)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142291
20.
Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy.
Radiother Oncol
; 189: 109920, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769968